Director/PDMR Shareholding

RNS Number : 0016V

BioVentix PLC

31 March 2023

 

Bioventix plc

("Bioventix" or the "Company")

Director/PDMR Shareholding

Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, was notified on 31 March 2023 of the following transactions in its ordinary shares of 5 pence each ("Ordinary Shares"):

Director	Role	Ordinary Shares sold	Average sale price per Ordinary Share	Ordinary Shares subsequently held	Percentage of issued share capital subsequently held
Ian Nicholson and Persons Closely Associated	Non-Executive Chairman	2,500	3,900	13,000	0.2%

The notifications below, which have been made in accordance with the requirements of the Market Abuse Regulation, provide further details.

For further information please contact:

Bioventix plc Peter Harrison Bruce Hiscock	Chief Executive Officer Chief Financial Officer	Tel: [phone]
finnCap Ltd Geoff Nash/Simon Hicks Alice Lane	Corporate Finance ECM	Tel: [phone]

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA")
a)	Name	Ian Nicholson
2.	Reason for the Notification
a)	Position/status	Chairman
b)	Initial notification/Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Bioventix plc
b)	LEI	213800225MHX7LZQY108
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the Financial instrument, type of instrument	Ordinary Shares of 5 pence each
	Identification code	GB00B4QVDF07
b)	Nature of the transaction	Sale of Ordinary Shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 3,877p 1,000
d)	Aggregated information: · Aggregated volume · Price	See 4(c)
e)	Date of the transaction	31 March 2023
f)	Place of the transaction	London Stock Exchange, AIM Market (XLON)

1	Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA")
a)	Name	Catherine Nicholson
2.	Reason for the Notification
a)	Position/status	PCA of Ian Nicholson, Chairman
b)	Initial notification/Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Bioventix plc
b)	LEI	213800225MHX7LZQY108
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the Financial instrument, type of instrument	Ordinary Shares of 5 pence each
	Identification code	GB00B4QVDF07
b)	Nature of the transaction	Sale of Ordinary Shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 3,915p 1,500
d)	Aggregated information: · Aggregated volume · Price	See 4(c)
e)	Date of the transaction	31 March 2023
f)	Place of the transaction	London Stock Exchange, AIM Market (XLON)

 

END

 

 

DSHEADDFDLFDEFA